Zydus Lifesciences Limited
Stock Forecast, Prediction & Price Target
Zydus Lifesciences Limited Financial Estimates
Zydus Lifesciences Limited Revenue Estimates
Zydus Lifesciences Limited EBITDA Estimates
Zydus Lifesciences Limited Earnings per Share Estimates
Passed | Analyst forecast | ||||||
---|---|---|---|---|---|---|---|
Metric | 3/31/2021 | 3/31/2022 | 3/31/2024 | 3/31/2026 | 3/31/2027 | ||
Revenue
% change YoY
| ₹148.21B N/A | ₹148.27B 0.04% | ₹195.47B 31.83% | Avg: ₹233.98B Low: ₹233.98B High: ₹233.98B avg. 19.70% | Avg: ₹239.22B Low: ₹239.22B High: ₹239.22B avg. 2.23% | ||
Net Income
% change YoY
| ₹21.33B N/A | ₹44.87B 110.31% | ₹38.59B -13.99% | Avg: ₹44.52B Low: ₹34.41B High: ₹56.37B avg. 15.35% | Avg: ₹41.65B Low: ₹31.88B High: ₹51.31B avg. -6.43% | ||
EBITDA
% change YoY
| ₹32.32B N/A | ₹34.28B 6.04% | ₹56.22B 63.99% | Avg: ₹56.14B Low: ₹56.14B High: ₹56.14B avg. -0.13% | Avg: ₹57.40B Low: ₹57.40B High: ₹57.40B avg. 2.23% | ||
EPS
% change YoY
| $20.84 N/A | $17.65 -15.30% | $38.14 116.09% | Avg: $44.42 Low: $34 High: $55.7 avg. 16.47% | Avg: $41.05 Low: $31.5 High: $50.7 avg. -7.58% | ||
Operating Expenses
% change YoY
| ₹67.15B N/A | ₹65.32B -2.72% | ₹83.10B 27.22% | Avg: ₹32.63B Low: ₹32.63B High: ₹32.63B avg. -60.72% | Avg: ₹33.36B Low: ₹33.36B High: ₹33.36B avg. 2.23% |
FAQ
What is Zydus Lifesciences Limited stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 4.45% in 2026-2027.
We have gathered data from 23 analysts. Their low estimate is 34.41B, average is 44.52B and high is 56.37B.
What is Zydus Lifesciences Limited stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 10.97% in 2026-2027.
We have gathered data from 29 analysts. Their low revenue estimate is ₹233.98B, average is ₹233.98B and high is ₹233.98B.
What is Zydus Lifesciences Limited stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 4.44% in 2026-2027.
We have gathered data from 23 analysts. Their low earnings per share estimate is $34, average is $44.42 and high is ₹55.7.